C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
M2 Acute Myelogenous Leukemia
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
AML with Maturation
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
M2 Acute Myeloid Leukemia with Maturation
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Acute M2 Myeloid Leukemia
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
M2 Acute Myeloblastic Leukemia
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Acute Myeloid Leukemia with Maturation
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
M2 Acute Myelogenous Leukemia with Maturation
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
FAB M2
|
C3250 |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Adenocarcinoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Primary Myelofibrosis
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Alcohol Consumption
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Refractory Anemia
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Rheumatoid Arthritis
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Ascites
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Asthma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Astrocytoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Barrett Esophagus
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Brain Neoplasm
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Burkitt Lymphoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Malignant Neoplasm
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Carcinoid Tumor
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Carcinoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Prostate Adenocarcinoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Mucinous Adenocarcinoma
|
TCGA |
C1879321 |
Acute Myeloid Leukemia (AML-M2) |
NCI |
Papillary Carcinoma
|
TCGA |